Publikationen 2025

Dahlmann P, Onkes M, Kunte S, Auer MK, Disko U, Wang K, Lottspeich C, Stüfchen I, Schweizer JROL, Mansour N, Brendel M, Schmid-Tannwald C, Fischer A, Nölting S, Auernhammer CJ, Reincke M, Bidlingmaier M, Werner RA, Kroiss M, Völter F. Quantitative [18F]FDOPA PET/CT for the characterization of biochemical phenotypes in paraganglioma and pheochromocytoma. EJNMMI Rep. 2025 Nov 24;9(1):40. doi: 10.1186/s41824-025-00275-3.


Stüfchen I, Williams TA, Schweizer JROL, Völter F, Zopp S, Petersenn E, Bidlingmaier M, Brüdgam D, Kroiss M, Oettle M, Schrenk M, Zimmermann P, Reincke M. Persistent renin suppression after unilateral adrenalectomy for primary aldosteronism: Implications for adverse outcome? J Clin Endocrinol Metab. 2025 Nov 1:dgaf595. doi: 10.1210/clinem/dgaf595. Online ahead of print


Ritzel K, Fedtke V, Then C, Nowak E, Vogel F, Braun L, Zopp S, Zimmermann P, Peters A, Heier M, Linkohr B, Roden M, Bidlingmaier M, Beuschlein F, Reincke M, Rubinstein G. Hypertension and kidney dysfunction despite long-term remission of Cushing's syndrome. J Endocrinol Invest. 2025 Nov;48(11):2671-2681. doi: 10.1007/s40618-025-02670-w. Epub 2025 Jul 29


Onkes M, Dahlmann P, Gesenhues A, Gacula SIG, Mansour N, Schweizer JROL, Stüfchen I, Lottspeich C, Wang K, Auer MK, Brendel M, Fischer A, Braunschweig T, Gildehaus FJ, Lindner S, Schmid-Tannwald C, Pfluger T, Auernhammer CJ, Nölting S, Werner RA, Reincke M, Bidlingmaier M, Kroiss M, Völter F. [18F]SiTATE-PET/CT for detection of pheochromocytomas and paragangliomas: comparison of biochemical secretion, genotype and imaging metrics. Eur J Nucl Med Mol Imaging. 2025 Nov;52(13):5175-5188. doi: 10.1007/s00259-025-07341-9. Epub 2025 May 30.


Biller BMK, Casagrande A, Elenkova A, Boguszewski CL, Jallad RS, Hu B, Hubina E, Fazeli PK, Fleseriu M, Snyder PJ, Strasburger CJ, Bidlingmaier M, Zhao Y, Soares B, Trainer PJ, Struthers RS, Krasner A, Gadelha MR. Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-Daily Oral Paltusotine Treatment. J Clin Endocrinol Metab. 2025 Oct 23:dgaf579. doi: 10.1210/clinem/dgaf579. Online ahead of print.


Tausendfreund O, Bidlingmaier M, Haenelt M, Kuehnle T, Deissler L, Martini S, Mueller K, Rippl M, Schilbach K, Schluessel S, Schmidmaier R, Drey M. Exploring GHBP as a surrogate of GH activity in multimorbid older adults: A cross-sectional study. Growth Horm IGF Res. 2025 Oct;82:101666. doi: 10.1016/j.ghir.2025.101666. Epub 2025 Sep 29


Remba-Shapiro I, Schweizer JROL, Moscona-Nissan A, Liebert KJP, Jones PS, Schilbach K, Naredo Rojas J, Adams M, Cheng VO, Tritos NA, Bidlingmaier M, Nachtigall LB. Insulin-like growth factor-I and symptoms of acromegaly according to time since somatostatin receptor ligand injection. Eur J Endocrinol. 2025 Sep 30;193(4):564-573. doi: 10.1093/ejendo/lvaf200.


Stüfchen I, Schweizer JROL, Völter F, Nowak E, Braun L, Kocabiyik J, Mederos Y Schnitzler M, Williams TA, Kunz S, Bidlingmaier M, Reincke M. The impact of endocrine disrupting chemicals on adrenal corticosteroids - A systematic review of epidemiological studies. Environ Res. 2025 Jul 1;276:121438. doi: 10.1016/j.envres.2025.121438. Epub 2025 Mar 19.


Bidlingmaier M, Reisch N. 11-Oxygenated Androgens Originate From the Adrenals. Period! And Now? J Clin Endocrinol Metab. 2025 May 19;110(6):e2094-e2095. doi: 10.1210/clinem/dgae638.


Tausendfreund O, Reif H, Bidlingmaier M, Martini S, Rippl M, Schilbach K, Schluessel S, Schmidmaier R, Drey M. Estimation of the biological variation of IGF-I in multimorbid geriatric patients and its clinical implications. Pituitary. 2025 May 10;28(3):59. doi: 10.1007/s11102-025-01530-3.


Arlien-Søborg MC, Radovick S, Boguszewski MCS, Bidlingmaier M, Johannsson G, Grimberg A, Ho KKY, Biller BMK, Choong CS, Hoffman AR, Backeljauw P, Boguszewski CL, Bollerslev J, Brue T, Chanson P, Christ E, Cianfarani S, Clayton PE, Cohen P, Dauber A, Fleseriu M, Gebauer J, Giustina A, Higham CE, Horikawa R, Höybye C, Juul A, Lodish M, Luo X, Mauras N, Miller KK, Melmed S, Neggers SJCMM, Karavitaki N, Rosenfeld R, Ross R, Savendahl L, Schilbach K, Collett-Solberg PF, Strasburger CJ, Tritos NA, van Santen HM, Yuen KCJ, Jorgensen JOL. Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society. Pituitary. 2025 May 7;28(3):57. doi: 10.1007/s11102-025-01526-z.


Ritzel K, Fazel J, August L, Fedtke V, Nowak E, Vogel F, Braun L, Zopp S, Then C, Künzel H, Reisch N, Zimmermann P, Thorsteinsdottir J, Schopohl J, Bidlingmaier M, Beuschlein F, Reincke M, Rubinstein G. Biochemical Control in Cushing's Syndrome: Outcomes of the Treatment in a Large Single Center Cohort. J Clin Endocrinol Metab. 2025 Mar 17;110(4):e1038-e1045. doi: 10.1210/clinem/dgae337.


Panarelli A, Schweizer JROL, Stüfchen I, Brüdgam D, Zopp S, Zimmermann P, Mulatero P, Deniz S, Beuschlein F, Reincke M, Nowak E. Prevalence and main characteristics of primary aldosteronism in bilateral macronodular adrenal disease: a systematic review of the literature. Eur J Endocrinol. 2025 Mar 3;192(3):S15-S25. doi: 10.1093/ejendo/lvaf020.


Pang Y, Gong S, Tetti M, Sun Z, Mir-Bashiri S, Bidlingmaier M, Knösel T, Wolf E, Reincke M, Kemter E, Williams TA. EGR1 regulates oxidative stress and aldosterone production in adrenal cells and aldosterone-producing adenomas. Redox Biol. 2025 Mar;80:103498. doi: 10.1016/j.redox.2025.103498. Epub 2025 Jan 15.


Sun Z, Kemter E, Pang Y, Bidlingmaier M, Wolf E, Reincke M, Williams TA. ATP2A3 in Primary Aldosteronism: Machine Learning-Based Discovery and Functional Validation. Hypertension. 2025 Feb;82(2):319-332. doi: 10.1161/HYPERTENSIONAHA.124.23817. Epub 2024 Dec 2.


Melmed S, di Filippo L, Fleseriu M, Mercado M, Karavitaki N, Gurnell M, Salvatori R, Tsagarakis S, Losa M, Maffei P, Pereira AM, Geer EB, Katznelson L, van der Lely AJ, Bollerslev J, Esposito D, Webb SM, Zatelli MC, Valassi E, Neggers S, Chanson P, Ho KKY, Ioachimescu AG, Biller BMK, Samson SL, Kaiser UB, Schilbach K, Luque RM, Casanueva FF, Shimon I, Boguszewski CL, Biermasz N, Colao A, Pirchio R, Lamberts SWJ, Kadioglu P, Buchfelder M, Frara S, Chiloiro S, Petersenn S, Gadelha MR, Puig-Domingo M, Luger A, Brue T, Beckers A, Ferone D, Clemmons DR, Greenman Y, Marazuela M, Mortini P, Strasburger CJ, Giustina A. Consensus on acromegaly therapeutic outcomes: an update. Nat Rev Endocrinol. 2025 Nov;21(11):718-737. doi: 10.1038/s41574-025-01148-2. Epub 2025 Aug 13. PMID: 40804505.


Störmann S, Schilbach K. Promising therapies for the treatment of acromegaly. Expert Opin Pharmacother. 2025 Apr;26(5):581-594. doi: 10.1080/14656566.2025.2474562. Epub 2025 Mar 11. PMID: 40025677.


Wang K, Fischer A, Maccio U, Zitzmann K, Robledo M, Lauseker M, Bauer J, Bechmann N, Gahr S, Maurer J, Peischer L, Reul A, Nieß H, Zimmermann P, Ilmer M, Schilbach K, Knösel T, Kroiss M, Fassnacht M, Müller SA, Morand GB, Huber A, Vetter D, Lehmann K, Kulcsar Z, Mohr H, Pellegata NS, Hantel C, Reincke M, Beuschlein F, Pacak K, Grossman AB, Auernhammer CJ, Nölting S. Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors. Eur J Endocrinol. 2025 Jan 6;192(1):46-60. doi: 10.1093/ejendo/lvae163. PMID: 39804847.


Castano JP, Dattani MT, Grozinsky-Glasberg S, Karavitaki N, Pavel ME, Andoniadou C, Alexandraki K, Capatina C, Cerbone M, Ferone D, Gan HW, Hofland J, Hofland L, Ibanez-Costa A, Ilie MD, Isidori AM, Korbonits M, Kos-Kudła B, Maghnie M, Mantovani G, Marazuela M, Raverot G, Scarpa A, Schilbach K, Theodoropoulou M, van Santen HM, Zatelli MC. EndoCompass Project: Research Roadmap for Pituitary and Neuroendocrine Tumor Endocrinology. Horm Res Paediatr. 2025;98(Suppl. 2):105-120. doi: 10.1159/000549145. Epub 2025 Nov 27. PMID: 41308051; PMCID: PMC12698125.


Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Haberbosch L, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Schilbach K, Lely AJV, Wass JAH, Melmed S, Casanueva FF. Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs). Pituitary. 2025 Jan 29;28(1):23. doi: 10.1007/s11102-024-01485-x. PMID: 39881009; PMCID: PMC11779774.


Chen SC, Lucas-Herald AK, Tang R, Tseretopoulou X, Alimussina M, Andrews D, Biller BMK, Boguszewski CL, Bryce J, Chen M, Clayton PE, Fleseriu M, Gebauer J, Ho KKY, Jorgensen JOL, Luo X, Miller BS, Neggers SJ, Sävendahl L, Schilbach K, Strasburger CJ, Takahashi Y, Vitali D, Yuen KCJ, Hoffman AR, Johannson G, Ahmed SF. Development of a Minimum Dataset for the Global Monitoring of the Safety and Efficacy of Growth Hormone Replacement in Adults With Growth Hormone Deficiency (AGHD). Clin Endocrinol (Oxf). 2025 Dec;103(6):841-851. doi: 10.1111/cen.15298. Epub 2025 Jul 21. PMID: 40692283; PMCID: PMC12583319.


Hinrichs A, Pafili K, Sancar G, Laane L, Zettler S, Torgeman M, Kessler B, Nono JL, Kunz S, Rathkolb B, Barosa C, Prehn C, Cecil A, Renner S, Kemter E, Kahl S, Szendroedi J, Bidlingmaier M, Jones JG, Hrabĕ de Angelis M, Roden M, Wolf E. Transient juvenile hypoglycemia in GH insensitive Laron syndrome pigs is associated with insulin hypersensitivity. Mol Metab. 2026 Jan;103:102273. doi: 10.1016/j.molmet.2025.102273. Epub 2025 Oct 20.


Stüfchen I, Schweizer JROL, Völter F, Nowak E, Braun L, Kocabiyik J, Mederos Y Schnitzler M, Williams TA, Kunz S, Bidlingmaier M, Reincke M. The impact of endocrine disrupting chemicals on adrenal corticosteroids - A systematic review of epidemiological studies. Environ Res. 2025 Jul 1;276:121438. doi: 10.1016/j.envres.2025.121438. Epub 2025 Mar 19. PMID: 40118322.